Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 4.890
-0.150 (-2.98%)
Apr 1, 2025, 2:52 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 333.80 million as of April 1, 2025. Its market cap has increased by 38.85% in one year.
Market Cap
333.80M
Enterprise Value
205.65M
Revenue
11.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.89
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 333.80M, a decrease of -53.67%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 344.04M | -14.29% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.16B |
| Nordhealth AS | 3.00B |
| Photocure ASA | 1.55B |
| Vistin Pharma ASA | 1.09B |
| Hofseth BioCare ASA | 1.02B |
| Omda AS | 844.92M |
| ArcticZymes Technologies ASA | 833.49M |
| Thor Medical ASA | 786.02M |